Cancer
A woman, Becky Williams, shares her heart-wrenching story of losing her partner Joe Morgan to bowel cancer, only to find love again with Tom Williams and experience another devastating loss when their baby Mabel tragically passed away due to a traumatic brain injury during labor. Her journey echoes that of
Cancer
Nick James, a furniture maker from Gosforth, was the first recruit to the Cancer Prevention Project 3 (CaPP3) trial in 2014, which aimed to explore the effect of low-dose aspirin on reducing bowel cancer risk in people with Lynch syndrome. The trial, led by Professor Sir John Burn from the
Cancer
The HER2-positive gastric cancer pipeline is a rapidly evolving space with over 20 companies and 20 pipeline drugs in various stages of development. DelveInsight's report "HER2 Positive Gastric Cancer - Pipeline Insight, 2025" provides a comprehensive analysis of the pipeline therapies, highlighting the promising emerging drugs,
Cancer
Fresh data on gene editing in gastric cancer have been presented by researchers from Chongqing University, shedding light on the enhancer landscape marked by histone H3K27ac modifications in diffuse-type gastric cancer tissues. The study aimed to elucidate the epigenetic remodeling mechanisms by which active enhancers regulate cachexia-related genes. The research
Cancer
Researchers at the University of Miyazaki have made significant discoveries in the treatment of gastric cancer, a type of cancer that is frequently associated with peritoneal metastasis and has a poor prognosis. According to recent research, photodynamic therapy (PDT) using a non-cytotoxic approach with talaporfin sodium (TS) may enhance the
Alcoholic beverages
A coalition of doctors, charities, and public experts is calling for clear and prominent health warning labels on all alcoholic drinks in the UK. The World Cancer Research Fund (WCRF) has written to Sir Keir Starmer, demanding that "bold and unambiguous" labels be placed on all drinks containing
Cancer
Research conducted in Lahore, Pakistan has revealed a novel cancer therapy using snake venom conjugated with silica nanoparticles. The study aimed to investigate the potential of employing silica nanoparticles as a vehicle for administering snake venom to enhance therapeutic efficacy while reducing systemic toxicity. According to the research, the combination
Cancer
Researchers at the University of Michigan have made significant progress in cancer gene therapy, leveraging the potential of polymeric nanoparticles to deliver messenger RNA therapeutics to the lungs. This breakthrough has far-reaching implications for the treatment of various pulmonary diseases, including cystic fibrosis, asthma, and lung cancer. The study, funded
Cancer
Researchers from Sun Yat-Sen University Cancer Center have detailed new data on the effectiveness of PD-1 antibody monotherapy in pediatric lymphoma patients. According to the study, pediatric lymphoma patients generally exhibit a favorable long-term survival rate. The use of anti-programmed death-1 (PD-1) monoclonal antibodies has significantly improved response rates in
Cancer
Researchers at China Medical University Hospital, led by Dr. Der-Yang Cho, in collaboration with Shine-On Biomedical Co., have developed the world's first targeted exosome drug delivery platform, SOB100, aimed at HLA-G. This innovative platform has shown promising efficacy in treating aggressive cancers such as breast cancer and glioblastoma.
Cancer
New research on stroke rehabilitation has highlighted the potential of machine learning algorithms to personalize and improve the recovery process for stroke survivors. According to a study published in the Journal of Engineering, stroke is a significant global public health challenge, ranking as the second leading cause of death after
Cancer
Researchers from Xi'an Jiaotong University have made a significant breakthrough in cancer gene therapy using engineered bacteria as intelligent microbots. These microbots, modified with drug-loaded liposomes, are designed to preferentially target and colonize tumors, overcoming the poor delivery efficacy of nanomedicines. The study, published in the journal Small,
